• Home
  • Spring 2019 Meeting

Spring 2019 Meeting

  • 2019-04-27
  • 17:00 - 22:00 (PDT)
  • Vancouver


Registration is closed

American Uveitis Society

Spring Meeting 2019

27 April 2019

Vancouver Convention Center

Vancouver British Columbia



 5:00 PM Social Hour
Vancouver Convention Center
Room West 119
 6:00 PM

Scientific Meeting

Vancouver Convention Center

Room West 118


Robert B Nussenblatt MD Memorial Lecture delivered by  Jonathan Braun, MD, PhD

University of California Los Angeles


Ronald E Smith MD Memorial Lecture delivered by

Robert Knight, PhD

University of California San Diego

 7:00 PM  Business Meeting
7:30 PM  Free Papers

Abstract submission is now closed.


chaired by

Tammy M. Martin, PhD     Casey Eye Institute, OHSU  &  Devers Eye Institute, LRI


Rooms 708/710/712, Colorado Convention Center


2 May, 2015






5.00 PM                     Social Hour (Room 703)



6.00 PM                     Plenary Session: Basis for and Uses of Biologic Drugs in Uveitis


Rachel Caspi, PhD

National Eye Institute, National Institutes of Health

Mirroring the Clinical and Immunological Complexity of Autoimmune Uveitis in Animal Models


Eric B. Suhler, MD, MPH

Oregon Health & Science University, VA Portland Health Care System

 “Biologic Warfare on Uveitis:  Perspectives from the Clinic



7.00 PM                     Business Meeting               



7.30 PM                     Free papers


7.30 PM         Gary Holland, MD: Interaction between Killer Immunoglobulin-like Receptor (KIR) Gene-HLA Combinations and Parasite Serotypes among Hispanic Individuals at Risk for Ocular Toxoplasmosis


7.45 PM         Douglas A. Jabs, MD, MBA: Long-term Outcomes of Cytomegalovirus Retinitis in the United States in the Era of Modern Antiretroviral Therapy


8.00 PM         John A. Gonzales, MD: Quality of Life Outcomes from a Randomized Clinical Trial for Noninfectious Intermediate, Posterior, and Pan- Uveitis

8.15 PM         Ali K. Tayyeba, MD: Management of End Stage Corneal Disease and Chronic Uveitic Hypotony by Combining the Boston Type 1 Keratoprosthesis with Pars Plana Vitrectomy and Silicone Oil Fill


8.30 PM         Daniel L Feiler, MD: Treatment of Uveitic Cystoid Macular Edema with Topical Difluprednate.


8.45 PM         Laura J. Kopplin, MD: Peginterferon alfa-2a (PEGASYS) in the Treatment of Inflammatory Cystoid Macular Edema


9.00 PM         Blake A. Isernhagen, MD: Autoimmune Retinopathy: A Guide for Clinicians Based on Recommendations of an Expert Panel

9.15 PM         Sarju S. Patel, MD: The Utility and Limitations of Wide-Field Autofluorescence in Inflammatory Choroiditis

9.30 PM         Friederike Mackensen, MD: Is There a Correlation Between Multiple Sclerosis and Fuchs Uveitis

Copyright © The American Uveitis Society
All rights reserved

700 18th Street South Suite 601
Birmingham Alabama 35233 USA

The American Uveitis Society is a 501(c)6 non-profit organization

Powered by Wild Apricot Membership Software